36 related articles for article (PubMed ID: 16874789)
1. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.
Aggarwal R; Liao K; Nair R; Ringold S; Costenbader KH
Arthritis Rheum; 2009 Nov; 61(11):1472-83. PubMed ID: 19877103
[TBL] [Abstract][Full Text] [Related]
2. Anti-cyclic citrullinated peptide antibody and pain sensitisation in patients with rheumatoid arthritis: a cross-sectional analysis.
Qiu YY; Neogi T; Muhammad LN; Song J; Bolster MB; Marder W; Heisler AC; Wohlfahrt A; Dunlop D; Lee YC
Ann Rheum Dis; 2023 Dec; 82(12):1638-1640. PubMed ID: 37468220
[No Abstract] [Full Text] [Related]
3. New markers and an old phenomenon: prozone effect disturbing detection of filaggrin (keratin) autoantibodies.
Dubois-Galopin F; Beauvillain C; Dubois D; Pillet A; Renier G; Jeannin P; Masson C; Chevailler A
Ann Rheum Dis; 2007 Aug; 66(8):1121-2. PubMed ID: 17626972
[No Abstract] [Full Text] [Related]
4. Etiology and Pathogenesis of Rheumatoid Arthritis-Interstitial Lung Disease.
Kim Y; Yang HI; Kim KS
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833957
[TBL] [Abstract][Full Text] [Related]
5. Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF).
Jee AS; Adelstein S; Bleasel J; Keir GJ; Nguyen M; Sahhar J; Youssef P; Corte TJ
J Clin Med; 2017 May; 6(5):. PubMed ID: 28471413
[TBL] [Abstract][Full Text] [Related]
6. Anti-cyclic citrullinated Peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis.
Yin Y; Liang D; Zhao L; Li Y; Liu W; Ren Y; Li Y; Zeng X; Zhang F; Tang F; Shan G; Zhang X
PLoS One; 2014; 9(4):e92449. PubMed ID: 24743261
[TBL] [Abstract][Full Text] [Related]
7. The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis.
Van Steendam K; Tilleman K; Deforce D
Rheumatology (Oxford); 2011 May; 50(5):830-7. PubMed ID: 21278075
[TBL] [Abstract][Full Text] [Related]
8. Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets?
Szekanecz Z; Soós L; Szabó Z; Fekete A; Kapitány A; Végvári A; Sipka S; Szücs G; Szántó S; Lakos G
Clin Rev Allergy Immunol; 2008 Feb; 34(1):26-31. PubMed ID: 18270854
[TBL] [Abstract][Full Text] [Related]
9. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
Lee AN; Beck CE; Hall M
Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
[TBL] [Abstract][Full Text] [Related]
10. Novel autoantibodies in rheumatoid arthritis.
Bonifacio AF; Alunno A; La Paglia GMC; Valentini E; Leone MC; Bartoloni E; Gerli R
Reumatismo; 2019 Apr; 71(1):1-12. PubMed ID: 30932437
[TBL] [Abstract][Full Text] [Related]
11. Association of anti-cyclic citrullinated peptide and anti-Sa/citrullinated vimentin autoantibodies in rheumatoid arthritis.
Rodríguez-Mahou M; López-Longo FJ; Sánchez-Ramón S; Estecha A; García-Segovia A; Rodríguez-Molina JJ; Carreño L; Fernández-Cruz E
Arthritis Rheum; 2006 Aug; 55(4):657-61. PubMed ID: 16874789
[No Abstract] [Full Text] [Related]
12. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
15. Duration of pre-rheumatoid arthritis anti-cyclic citrullinated peptide positivity is positively associated with age at seroconversion.
Bos WH; Nielen MM; Dijkmans BA; van Schaardenburg D
Ann Rheum Dis; 2008 Nov; 67(11):1642. PubMed ID: 18854513
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
